Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD) Iris Viejo Boyano, Paul José Hernández Velasco, Eduardo Gutiérrez Martínez

The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis Xuanwei Li, Wenlai Li, Yue Li, Chuanjiang Dong, Ping Zhu

Molecular diagnosis of autosomal dominant polycystic kidney disease Torra Balcells, Ars Criach